Toggle Nav

Anacetrapib (MK-0859)

In stock
Catalog No.
A4375
RhCETP/mutant CETP(C13S) inhibitor
Grouped product items
SizePriceStock Qty
10mM (in 1mL DMSO)
$170.00
In stock
5mg
$120.00
In stock
10mg
$200.00
In stock
50mg
$580.00
In stock
200mg
$1,480.00
In stock

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Anacetrapib, also known as MK-0859, is a potent and selective inhibitor of cholesteryl ester transfer protein (CETP) that exhibits strong inhibition against CETP-mediated transfer of cholesteryl esters and triglycerides with values of inhibition constant IC50 of 16 nM and 29 nM respectively. Anacetrapib is mainly metabolized by CYP3A4 through O-demethylation, hydroxylation on the biphenyl moiety and hydroxylation on the isopropyl side chain resulting in three oxidative metabolites M1, M2 and M3 respectively. Anacetrapib is being investigated for the treatment of primary hypercholesterolemia and mixed hyperlipidemia due to its impressive effects to lower low-density lipoprotein (LDL) cholesterol levels and increase high-density lipoprotein (HDL) cholesterol levels without any associated major adverse events.

Reference

Tan EY, Hartmann G, Chen Q, Pereira A, Bradley S, Doss G, Zhang AS, Ho JZ, Braun MP, Dean DC, Tang W, Kumar S. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys. Drug Metab Dispos. 2010;38(3):459-473.

Kumar S, Tan EY, Hartmann G, Biddle Z, Bergman AJ, Dru J, Ho JZ, Jones AN, Staskiewicz SJ, Braun MP, Karanam B, Dean DC, Gendrano IN, Graves MW, Wagner JA, Krishna R. Metabolism and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in humans. Drug Metab Dispos. 2010;38(3):474-483

Product Citation

Chemical Properties

Physical AppearanceA solid
StorageStore at -20°C
M.Wt637.51
Cas No.875446-37-0
FormulaC30H25F10NO3
SynonymsMK 0859, MK0859
Solubility≥31.9 mg/mL in DMSO, ≥86.6 mg/mL in EtOH, <2.23 mg/mL in H2O
Chemical Name(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-1,3-oxazolidin-2-one
SDFDownload SDF
Canonical SMILESCC1C(OC(=O)N1CC2=C(C=CC(=C2)C(F)(F)F)C3=CC(=C(C=C3OC)F)C(C)C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
Shipping ConditionEvaluation sample solution : ship with blue ice.All other available size: ship with RT , or blue ice upon request
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.

Biological Activity

Description Anacetrapib is a potent, selective, reversible inhibitor of rhCETP and mutant CETP(C13S) with IC50 values of 7.9 nM and 11.8 nM, respectively.
Targets rhCETP mutant CETP(C13S)        
IC50 7.9 nM 11.8 nM        

Quality Control

Chemical structure

Anacetrapib (MK-0859)

Related Biological Data

Anacetrapib (MK-0859)